Remimazolam as an Adjunct to General Anesthesia in Children: Adverse Events and Outcomes in a Large Cohort of 418 Cases

Remimazolam was first approved in 2020 as a general anesthetic for adults and still does not have pediatric labeling. Our study will be the first pilot program that administers remimazolam as an adjunct to a general endotracheal anesthetic in children. Between August 2020 and December 2022, electron...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimoto, Yoshitaka, Hirano, Tatsuya, Kuratani, Norifumi, Cavanaugh, David, Mason, Keira P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299672/
https://www.ncbi.nlm.nih.gov/pubmed/37373624
http://dx.doi.org/10.3390/jcm12123930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299672/
https://www.ncbi.nlm.nih.gov/pubmed/37373624
http://dx.doi.org/10.3390/jcm12123930

Ejemplares similares